packageIdroxioleicAcid

idroxioleic acid

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Idroxioleic acid (2-hydroxyoleic acid) is an investigational antineoplastic agent being studied as a cancer treatment. It is not yet an approved medicine and remains in clinical investigation, with no marketing authorisation such as from the European Medicines Agency.

Summary written by glm-5.3-flash from Wikidata Q28816084 and the WHO ATC classification; not checked by a person.

name:idroxioleic acid
ATC codes:L01XX85
DrugBank:DB18213
ChEBI:143096
Wikidata:Q28816084
formula:C18H34O3
molar mass:298.467 g/mol (knowledgebase (DrugBank calculated))

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown